• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深入的外周 CD4 T 谱与肌无力危象相关。

In-depth peripheral CD4 T profile correlates with myasthenic crisis.

机构信息

Department of Neurology, Huashan Hospital Fudan University, Shanghai, China.

Department of Biostatistics, School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, China.

出版信息

Ann Clin Transl Neurol. 2021 Apr;8(4):749-762. doi: 10.1002/acn3.51312. Epub 2021 Feb 22.

DOI:10.1002/acn3.51312
PMID:33616296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8045923/
Abstract

OBJECTIVE

Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies against neuromuscular junctions. Myasthenic crisis (MC) represents the most severe state of MG with high in-hospital mortality. We aimed to identify immune signatures using in-depth profiling in MC, and to assess the correlations between immune biomarkers with clinical severity longitudinally.

METHODS

We studied 181 participants including 57 healthy controls, 96 patients with MG who never experienced crisis and 28 MC patients from December 2018 through June 2020. Follow-up visits occurred prospectively from crisis to 6 months off-mechanical ventilation. The frequencies of 20 CD4 T subpopulations and 18 serum cytokines were associated with clinical scores using correlations and principal component analysis.

RESULTS

Patients in crisis exhibited a proinflammatory CD4 T response with elevated Th1 (P = 0.026), and Th17 cells (P = 0.032); decreased T follicular helper 2 (Tfh2) cells (P < 0.001), Tnaive in Tfh cells (P < 0.001), ICOS Tfh cells (P = 0.017), and T central memory in Tfh (P = 0.022) compared with controls, and increased frequencies of Tregs (P = 0.026) and Tfh17 (P = 0.045) compared with non-crisis MG. Cytokine cascade was identified in crisis including the ones associated with Th1 (IL-1β/2/12p70/18/27/IFN-γ/TNF-α), Th2 (IL-4/5/13), Th17 (IL-6/17A/21/22/23/GM-CSF), Th9 (IL-9), and Treg (IL-10). Longitudinally, seven immune biomarkers including Tregs, IL-2/4/17A/IFN-γ/TNF-α/GM-CSF had significant correlations with MG-activities of daily living score.

INTERPRETATION

Vigorous inflammatory CD4 T signatures were identified in MC and are associated with clinical severity. Future research is needed to explore its potential candidacy for therapeutic intervention and predicting impending crisis.

摘要

目的

重症肌无力(MG)是一种由针对神经肌肉接头的自身抗体引起的自身免疫性疾病。肌无力危象(MC)代表 MG 最严重的状态,院内死亡率高。我们旨在使用 MC 中的深度分析来识别免疫特征,并评估免疫生物标志物与临床严重程度的纵向相关性。

方法

我们研究了 181 名参与者,包括 57 名健康对照者、96 名从未经历过危象的 MG 患者和 2018 年 12 月至 2020 年 6 月期间的 28 名 MC 患者。从危机到 6 个月停用机械通气进行前瞻性随访。使用相关性和主成分分析将 20 种 CD4 T 亚群和 18 种血清细胞因子的频率与临床评分相关联。

结果

处于危象中的患者表现出促炎 CD4 T 反应,Th1 细胞增多(P=0.026),Th17 细胞增多(P=0.032);T 滤泡辅助 2(Tfh2)细胞减少(P<0.001),Tfh 细胞中的 Tnaive(P<0.001),ICOS Tfh 细胞(P=0.017)和 Tfh 中的 T 中央记忆细胞(P=0.022)与对照组相比,Tregs(P=0.026)和 Tfh17(P=0.045)的频率增加与非危机性 MG 相比。在危象中鉴定出细胞因子级联,包括与 Th1(IL-1β/2/12p70/18/27/IFN-γ/TNF-α)、Th2(IL-4/5/13)、Th17(IL-6/17A/21/22/23/GM-CSF)、Th9(IL-9)和 Treg(IL-10)相关的细胞因子。纵向分析显示,包括 Tregs、IL-2/4/17A/IFN-γ/TNF-α/GM-CSF 在内的 7 种免疫生物标志物与 MG 日常生活活动评分显著相关。

结论

在 MC 中鉴定出强烈的炎症性 CD4 T 特征,与临床严重程度相关。需要进一步研究以探索其作为治疗干预和预测即将发生的危象的潜在候选物的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb0/8045923/bdb92e98cfc0/ACN3-8-749-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb0/8045923/952fcba48701/ACN3-8-749-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb0/8045923/9e572e998f27/ACN3-8-749-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb0/8045923/ee2ecd6debee/ACN3-8-749-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb0/8045923/bdb92e98cfc0/ACN3-8-749-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb0/8045923/952fcba48701/ACN3-8-749-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb0/8045923/9e572e998f27/ACN3-8-749-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb0/8045923/ee2ecd6debee/ACN3-8-749-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb0/8045923/bdb92e98cfc0/ACN3-8-749-g001.jpg

相似文献

1
In-depth peripheral CD4 T profile correlates with myasthenic crisis.深入的外周 CD4 T 谱与肌无力危象相关。
Ann Clin Transl Neurol. 2021 Apr;8(4):749-762. doi: 10.1002/acn3.51312. Epub 2021 Feb 22.
2
CD4 T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS.重症肌无力患者的 CD4 T 细胞表现为 IL-21、IL-4 和 IL-17A 产生增加,以及 PD-1 和 ICOS 的高表达。
Front Immunol. 2020 May 19;11:809. doi: 10.3389/fimmu.2020.00809. eCollection 2020.
3
Effects of Follicular Helper T Cells and Inflammatory Cytokines on Myasthenia Gravis.滤泡辅助性T细胞和炎性细胞因子对重症肌无力的影响。
Curr Mol Med. 2019;19(10):739-745. doi: 10.2174/1566524019666190827162615.
4
Immune Skew of Circulating Follicular Helper T Cells Associates With Myasthenia Gravis Severity.循环滤泡辅助性 T 细胞免疫偏倚与重症肌无力严重程度相关。
Neurol Neuroimmunol Neuroinflamm. 2021 Jan 12;8(2). doi: 10.1212/NXI.0000000000000945. Print 2021 Mar.
5
Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.伴有抗乙酰胆碱受体(AChR)和肌肉特异性激酶(MuSK)抗体的重症肌无力患者的细胞因子差异变化
PLoS One. 2015 Apr 20;10(4):e0123546. doi: 10.1371/journal.pone.0123546. eCollection 2015.
6
Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis.T 滤泡辅助细胞产生白细胞介素-17 的失衡促进 MuSK 抗体阳性重症肌无力的促炎反应。
J Neuroimmunol. 2020 Aug 15;345:577279. doi: 10.1016/j.jneuroim.2020.577279. Epub 2020 May 27.
7
Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients.他克莫司抑制 MuSK 抗体阳性重症肌无力患者的 Th1 和 Th17 反应。
Exp Neurol. 2019 Feb;312:43-50. doi: 10.1016/j.expneurol.2018.11.006. Epub 2018 Nov 22.
8
Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.过继转导 RelB 沉默的骨髓树突状细胞可抑制实验性自身免疫性重症肌无力,与 Th17/Th1 向 Th2 和 FoxP3+调节性 T 细胞表型的转变有关。
Inflamm Res. 2010 Mar;59(3):197-205. doi: 10.1007/s00011-009-0087-6. Epub 2009 Sep 19.
9
Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.肌肉特异性激酶(MuSK)型重症肌无力中CD4和CD8 T细胞反应的特征
J Autoimmun. 2014 Aug;52:130-8. doi: 10.1016/j.jaut.2013.12.005. Epub 2013 Dec 28.
10
Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.γ干扰素、白细胞介素-4及转化生长因子-β mRNA在多发性硬化症和重症肌无力中的表达
Acta Neurol Scand Suppl. 1994;158:1-58.

引用本文的文献

1
Short-term treatment of CIDP with efgartigimod: a case series in China.用艾加莫德治疗慢性炎性脱髓鞘性多发性神经病的短期治疗:中国的病例系列
Front Immunol. 2025 May 1;16:1533167. doi: 10.3389/fimmu.2025.1533167. eCollection 2025.
2
Pro-inflammatory cytokines in myasthenia gravis: a systematic review and meta-analysis.重症肌无力中的促炎细胞因子:系统评价与荟萃分析
Neurol Sci. 2025 May 10. doi: 10.1007/s10072-025-08218-3.
3
Myasthenia gravis in 2025: five new things and four hopes for the future.2025年的重症肌无力:五件新事与对未来的四点期望。

本文引用的文献

1
The role of T cells in pemphigus vulgaris and bullous pemphigoid.T 细胞在寻常型天疱疮和大疱性类天疱疮中的作用。
Autoimmun Rev. 2020 Nov;19(11):102661. doi: 10.1016/j.autrev.2020.102661. Epub 2020 Sep 14.
2
Generation of a novel CD30 B cell subset producing GM-CSF and its possible link to the pathogenesis of systemic sclerosis.生成一种新型的产生 GM-CSF 的 CD30+B 细胞亚群,及其与系统性硬化症发病机制的可能联系。
Clin Exp Immunol. 2020 Sep;201(3):233-243. doi: 10.1111/cei.13477. Epub 2020 Jul 14.
3
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial.
J Neurol. 2025 Feb 22;272(3):226. doi: 10.1007/s00415-025-12922-7.
4
Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series.依氟鸟氨酸作为重症肌无力危象的一种有前途的附加治疗方法:一项前瞻性病例系列研究。
Front Immunol. 2024 Jul 29;15:1418503. doi: 10.3389/fimmu.2024.1418503. eCollection 2024.
5
The safety and efficacy profile of eculizumab in myasthenic crisis: a prospective small case series.依库珠单抗治疗重症肌无力危象的安全性和有效性:一项前瞻性小病例系列研究。
Ther Adv Neurol Disord. 2024 Jul 26;17:17562864241261602. doi: 10.1177/17562864241261602. eCollection 2024.
6
An angel or a devil? Current view on the role of CD8 T cells in the pathogenesis of myasthenia gravis.天使还是恶魔?CD8 T 细胞在重症肌无力发病机制中的作用的当前观点。
J Transl Med. 2024 Feb 20;22(1):183. doi: 10.1186/s12967-024-04965-7.
7
Dysregulated Long Non-coding RNAs in Myasthenia Gravis- A Mini-Review.重症肌无力中失调的长链非编码RNA——一篇综述
Curr Mol Med. 2025;25(1):2-12. doi: 10.2174/0115665240281531231228051037.
8
Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics.利用单细胞转录组学研究肌无力危象中细胞因子血症的外周免疫图谱。
J Transl Med. 2023 Aug 24;21(1):564. doi: 10.1186/s12967-023-04421-y.
9
Novel pathophysiological insights in autoimmune myasthenia gravis.自身免疫性重症肌无力的新病理生理学见解。
Curr Opin Neurol. 2022 Oct 1;35(5):586-596. doi: 10.1097/WCO.0000000000001088. Epub 2022 Aug 4.
10
Increased serum IL-2, IL-4, IL-5 and IL-12p70 levels in AChR subtype generalized myasthenia gravis.乙酰胆碱受体亚型全身性重症肌无力患者血清白介素-2、白介素-4、白介素-5 和白介素-12p70 水平升高。
BMC Immunol. 2022 May 27;23(1):26. doi: 10.1186/s12865-022-00501-8.
托珠单抗与硫唑嘌呤治疗高复发视神经脊髓炎谱系疾病的安全性和有效性(TANGO):一项开放标签、多中心、随机、2 期临床试验。
Lancet Neurol. 2020 May;19(5):391-401. doi: 10.1016/S1474-4422(20)30070-3.
4
Myasthenic crisis demanding mechanical ventilation: A multicenter analysis of 250 cases.需要机械通气的肌无力危象:250 例多中心分析。
Neurology. 2020 Jan 21;94(3):e299-e313. doi: 10.1212/WNL.0000000000008688. Epub 2019 Dec 4.
5
Predictive Score for In-Hospital Mortality of Myasthenic Crisis: A Retrospective Chinese Cohort Study.重症肌无力危象住院患者病死率预测评分:一项回顾性中国队列研究。
Eur Neurol. 2019;81(5-6):287-293. doi: 10.1159/000503961. Epub 2019 Oct 29.
6
Anti IL-17 in psoriasis.治疗银屑病的抗白细胞介素-17 疗法。
Expert Rev Clin Immunol. 2019 Nov;15(11):1185-1194. doi: 10.1080/1744666X.2020.1679625. Epub 2019 Oct 16.
7
Intravenous immunoglobulin promotes the proliferation of CD4CD25 Foxp3 regulatory T cells and the cytokines secretion in patients with Guillain-Barré syndrome in vitro.静脉注射免疫球蛋白促进格林-巴利综合征患者体外 CD4CD25 Foxp3 调节性 T 细胞的增殖和细胞因子分泌。
J Neuroimmunol. 2019 Nov 15;336:577042. doi: 10.1016/j.jneuroim.2019.577042. Epub 2019 Aug 26.
8
Effects of Follicular Helper T Cells and Inflammatory Cytokines on Myasthenia Gravis.滤泡辅助性T细胞和炎性细胞因子对重症肌无力的影响。
Curr Mol Med. 2019;19(10):739-745. doi: 10.2174/1566524019666190827162615.
9
Diagnosis and treatment of myasthenia gravis.重症肌无力的诊断与治疗。
Curr Opin Rheumatol. 2019 Nov;31(6):623-633. doi: 10.1097/BOR.0000000000000647.
10
The pathogenicity of Th17 cells in autoimmune diseases.Th17 细胞在自身免疫性疾病中的致病性。
Semin Immunopathol. 2019 May;41(3):283-297. doi: 10.1007/s00281-019-00733-8. Epub 2019 Mar 19.